Activation of Nrf2 and HIF-1α exerts neuroprotective effects in models of neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, and ischemic stroke. This evidence concerns the gene HIF1A and early-onset autosomal dominant Alzheimer disease.